Nociceptive vs Neuropathic Pain Explained

If you've been told your pain is one thing and treated for another, you know the cost. Months on a medication that was never going to work for your kind of pain. Side effects that piled up for no benefit. A chart that quietly started using the word "treatment-resistant." Figuring out what kind of chronic pain you actually have is often the step that gets skipped. It shouldn't be.

If your pain is aching, throbbing, and tied to a clear injury or inflammation, it's probably nociceptive (pain from damaged tissue). If it burns, shoots, or feels electric, especially without an obvious cause, it's probably neuropathic (pain from damaged nerves).

Many chronic conditions involve both, and a third category called nociplastic pain explains some of the cases that fit neither box. The treatments for each are different, which is why getting the classification right changes what works.

What Is Nociceptive Pain?

Nociceptive pain comes from actual or threatened tissue damage. Specialized nerve endings called nociceptors detect injury, inflammation, or noxious stimuli in muscles, joints, bones, skin, or internal organs, and send accurate signals to the brain. The nervous system itself is working correctly. It's reporting what it finds.

You can usually point to where it hurts. It tends to ache, throb, or feel sharp and pressure-like. It typically worsens with movement or direct pressure and improves with rest, ice, or anti-inflammatory treatments. Osteoarthritis, mechanical low back pain, sprains and strains, tendinitis, post-surgical pain, fractures, and overuse muscle pain all fall in this category.

Nociceptive pain usually fades as the tissue heals. When it doesn't, something more complex may be going on, and a reassessment of pain type becomes relevant. Pain that lingers also tends to take more than a physical toll.

The hidden impact often shows up as sleep disruption, depression, or anxiety alongside the physical symptoms, and you probably already know that part.

What Is Neuropathic Pain?

Neuropathic pain comes from damage or disease in the nerves themselves. The IASP definition describes it as pain caused by a lesion or disease of the somatosensory nervous system. The nerves send false, amplified, or distorted signals even when no tissue damage is present, and the pain can persist long after any original injury has healed.

It typically feels like burning, shooting, stabbing, or electric shock-like sensations that arrive unprovoked. Allodynia is a hallmark: pain triggered by a bedsheet, a light breeze, or the seam of a sock. Numbness and tingling usually coexist in the same area. Symptoms tend to worsen at night, which is why sleep disruption is one of the most disabling parts.

Diabetic peripheral neuropathy, sciatica from nerve root compression, postherpetic (shingles) pain, trigeminal neuralgia, phantom limb pain, Complex Regional Pain Syndrome (CRPS), central neuropathic pain from spinal cord injury or stroke, and chemotherapy-induced peripheral neuropathy all fit here.

Population studies estimate that 6.9% to 10% of adults live with pain that has neuropathic characteristics, and roughly 1 in 5 people with chronic pain report neuropathic symptoms. The cumulative emotional exhaustion of living with that day after day is often as disabling as the pain itself.

Nociplastic Pain, the Third Category

In 2017, the IASP formally adopted a third mechanism called nociplastic pain. Neither tissue nor nerve is demonstrably damaged, but the central nervous system's pain pathways have become dysregulated. The system amplifies signals and produces pain in response to things that shouldn't hurt. The mechanism is real neurology, and it's measurable. The nervous system has learned to overreact.

Fibromyalgia is the textbook example. Other conditions associated with nociplastic mechanisms include irritable bowel syndrome, tension-type headache, temporomandibular disorder, and some chronic widespread pain. Sometimes anxiety body aches overlap with this picture, since persistent stress can amplify pain processing through similar central mechanisms.

If your scans look normal but the pain is disabling, nociplastic pain is worth raising with your clinician.

Key Differences at a Glance

Where Common Conditions Get Tricky

Most chronic pain conditions fall predominantly into one category, but the mixed cases are where misdiagnosis tends to happen.

Sciatica

Sciatica looks neuropathic on paper. Pain radiates from a compressed lumbar nerve root, with the burning and shooting quality of nerve damage. But the IASP notes that some back-related leg pain is actually nociceptive referred pain from spinal structures rather than true neuropathic pain. The treatments differ, which is why accurate diagnosis matters.

Low Back Pain

Low back pain is usually nociceptive when it stays in the back and is mechanical or inflammatory. It becomes mixed or neuropathic when nerve root compression produces radiating leg pain (radiculopathy).

Osteoarthritis

Osteoarthritis is predominantly nociceptive. Joint inflammation and cartilage damage produce localized aching. But long-standing arthritis can develop a nociplastic component as the nervous system becomes more sensitive over time, which helps explain why some people's pain outpaces what their imaging would predict.

CRPS

CRPS is predominantly neuropathic, often with nociplastic features. Disproportionate pain develops after an injury, frequently with sensory and autonomic changes.

Migraine, Headache, and Pelvic Pain

Migraine, tension headache, chronic pelvic pain, and endometriosis pain all tend to involve mixed mechanisms, with nociplastic features increasingly recognized as part of the picture.

If a condition has been managed for months or years without much improvement, it's worth asking whether the working diagnosis still fits the mechanism.

Why Correct Classification Changes Everything

When the classification is wrong, the underlying mechanism doesn't get addressed. Side effects pile up. After enough failed attempts, the chart often gains a quiet new label: "treatment-resistant." That label can be misleading. If your neuropathic pain has been treated for two years with NSAIDs and steroid injections, you haven't failed treatment. You've been treated for the wrong mechanism.

The pharmacology lines up with this. NSAIDs target tissue inflammation and have no first-line role in neuropathic pain. Gabapentinoids target excitable pain-signaling nerves and don't address acute tissue-based pain well. Even with the correct diagnosis, response rates are imperfect.

In the NeuPSIG analysis, tricyclic antidepressants like amitriptyline had a number needed to treat (NNT) of about 3.6 for 50% pain relief. That means roughly 1 in 3 to 4 patients achieve meaningful relief from the most effective first-line drug. Other first-line options sit higher: gabapentin at 7.2, pregabalin at 7.7, SNRIs around 6.4. Of course, results vary by individual.

That's one reason treatment success today is measured in what you get back: sleep, mobility, work, the ability to sit through a meal or a conversation. Pain scores alone don't capture that.

How Treatments Differ by Pain Type

NNT figures from the NeuPSIG/IASP 2015 meta-analysis (Finnerup et al., Lancet Neurology). NNT = Number Needed to Treat for one person to achieve 50% pain relief; lower is better. Response rates vary by individual.

A note on opioids: for chronic nociceptive pain, the landmark SPACE trial found no significant difference in function between opioid and nonopioid groups, with pain intensity actually slightly better in the nonopioid group. For neuropathic pain, opioids are usually reserved as second- or third-line because of their harm profiles.

If opioid concerns are part of your situation, reducing reliance is a decision to make with your clinician, not on your own.

How Clinicians Tell the Difference

A good clinician starts by listening to how you describe your pain. Aching, throbbing pain that worsens with pressure tends to point toward nociceptive. Burning, shooting, or electric sensations with allodynia point toward neuropathic. Where you feel it, when it started, what makes it worse, and what's failed to help: all of it is diagnostic.

Three validated screening tools help formalize the picture. The DN4 is clinician-administered, while the painDETECT and the S-LANSS are both self-report. They are screening aids, not standalone diagnostic instruments. For a more definitive diagnosis, the IASP uses a three-level grading system: possible, probable, and definite neuropathic pain.

Where Innerwell Fits

For tissue-driven nociceptive pain, the standard care pathway of anti-inflammatory medications, physical therapy, and procedural care is often appropriate. For neuropathic or nociplastic pain that hasn't responded to those approaches, a different framework may be worth considering.

Who the Program Is For

Innerwell's 12-week at-home ketamine program is built for adults whose chronic pain involves the nervous system itself: neuropathic pain and pain driven by central sensitization. Ketamine is used off-label for chronic pain.

It blocks NMDA receptors involved in central sensitization and may help reduce pain intensity, but lasting functional improvement comes from a structured care plan with clinician-guided dosing, monitoring, and behavioral support.

How the Program Works

A few things matter about how the program is set up. The medication is sublingual tablets you take at home, rather than infusions you travel to receive. When getting to a clinic is part of what hurts, removing the trip matters.

The clinicians are licensed and pain-specialized. Symptom tracking happens between sessions, so dose and response can be adjusted based on what's actually changing in your daily life.

What to Expect

Licensed clinicians specialized in pain management, oral ketamine tablets at home, roughly four clinician check-ins per month, four psychiatric consults, and ongoing symptom tracking over 12 weeks. Many patients see improvement in pain intensity, sleep, mobility, and daily function within the first month. Results vary.

Some patients are also able to reduce their reliance on opioids over time with clinical guidance, but that decision is made together with the clinician. Innerwell's program is a chronic pain management program, not a detox or addiction treatment service. Both insurance and self-pay paths will be available.

See if you're eligible for Innerwell's structured pain management program.

Frequently Asked Questions

Can pain be both nociceptive and neuropathic at the same time?

Yes, and it's common. Low back pain with radiculopathy involves nociceptive pain from spinal structures plus neuropathic pain from compressed nerve roots. Chronic post-surgical pain, advanced osteoarthritis, and many cancer-related pain syndromes also involve mixed mechanisms. Mixed pain is one reason a single drug rarely does the whole job, and one reason your treatment plan probably needs more than one lever.

Does an MRI or scan tell you whether pain is neuropathic?

Not directly. Imaging shows tissue and structural problems, but it can't measure how your nerves are conducting signals. A normal scan doesn't rule out neuropathic or nociplastic pain. In fibromyalgia, scans are typically normal despite severe pain. Diagnosis usually relies on the pattern of symptoms, screening tools like the DN4 or painDETECT, and where appropriate, nerve conduction studies or electromyography.

If gabapentin didn't help, does that mean my pain isn't neuropathic?

Not necessarily. The NeuPSIG meta-analysis found gabapentin has an NNT of 7.2, meaning most people who take it won't get 50% pain relief even when the pain is well-defined neuropathic. A non-response to one drug doesn't reclassify your pain. It usually means trying another first-line option, like a TCA or SNRI, or combining approaches before concluding the mechanism isn't neuropathic.

Is central sensitization nociceptive or neuropathic?

Neither, in the strict sense. Central sensitization describes an amplified pain response from the central nervous system, and it's the core mechanism behind nociplastic pain. It can also develop on top of long-standing nociceptive or neuropathic pain, which is why some conditions evolve in their mechanism over time. Treatments that target central pain processing, including some that affect NMDA receptors, work differently than tissue- or nerve-targeted drugs.

Why does my pain get worse at night?

This is a hallmark of neuropathic and nociplastic pain. Several factors converge in the evening. Distraction drops, body temperature shifts, posture changes, and the body's natural pain-dampening neurochemistry runs lower. Nighttime worsening is one of the screening questions on the DN4 and painDETECT for a reason. It's a real diagnostic clue rooted in how your nervous system processes signals at the end of the day